Difficult‐to‐Treat Rheumatoid Arthritis With Concomitant Yao Syndrome With Response to Dual‐Inhibitor Therapy

Documenti analoghi

• Whole‐Blood RNA Sequencing Profiling of Patients With Rheumatoid Arthritis Treated With Tofacitinib
  di: Chiara Bellocchi, et al.
  Pubblicazione: (2025)
• Characterization of Second‐Line Therapy After First JAK Inhibitor Use: Results From the CorEvitas Rheumatoid Arthritis Registry
  di: Joshua F. Baker, et al.
  Pubblicazione: (2025)
• Circulating Adipokines and Response to Treatment in Patients With Early Rheumatoid Arthritis
  di: Georgios K. Vasileiadis, et al.
  Pubblicazione: (2024)
• Real‐World Treatment and Care Patterns in Patients With Rheumatoid Arthritis Initiating First‐Line Tumor Necrosis Factor Inhibitor Therapy in the United States
  di: Colin Edgerton, et al.
  Pubblicazione: (2024)
• Predicting Flare in Patients With Rheumatoid Arthritis in Biologic Induced Remission, on Tapering, and on Stable Therapy
  di: Hanna Gul, et al.
  Pubblicazione: (2024)